Home Cart Sign in  
Chemical Structure| 1233706-88-1 Chemical Structure| 1233706-88-1

Structure of CAY10650
CAS No.: 1233706-88-1

Chemical Structure| 1233706-88-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

CAY10650 is a highly potent cytosolic phospholipase A2α (cPLA2α) inhibitor with an IC50 value of 12 nM.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of CAY10650

CAS No. :1233706-88-1
Formula : C28H25NO6
M.W : 471.50
SMILES Code : O=C(CN1C(C=CC(C(O)=O)=C2)=C2C(C(C(C)C)=O)=C1)COC(C=C3)=CC=C3OC4=CC=CC=C4
MDL No. :MFCD18206878

Safety of CAY10650

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
rat atrial cells 120.0 nM CAY10650 significantly inhibited ET-1-induced upregulation of NOX4 expression Korean J Physiol Pharmacol. 2021 Mar 1;25(2):159-166
human neutrophils 12 nM 30 min Inhibited phosphorylation of cPLA2-α, reduced lipid droplet formation and PGE2 secretion Sci Rep. 2020 Jul 3;10(1):10976

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rat Isolated perfused beating rat hypoxic atrial model Perfusion 120.0 nM After one control period, one treatment cycle was followed by four cycles of infusion of the treatment agent plus hypoxia. CAY10650 significantly inhibited ET-1-induced upregulation of NOX4 expression Korean J Physiol Pharmacol. 2021 Mar 1;25(2):159-166

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.12mL

0.42mL

0.21mL

10.60mL

2.12mL

1.06mL

21.21mL

4.24mL

2.12mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories